Pineapple Express Cannabis Co PNXP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PNXP is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.50
- Day Range
- $1.74–1.74
- 52-Week Range
- $1.24–2.55
- Bid/Ask
- $1.00 / $1.74
- Market Cap
- $34.51 Mil
- Volume/Avg
- 443 / 374
Key Statistics
- Price/Earnings (Normalized)
- 73.13
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Pineapple Express Cannabis Co along with its subsidiaries, serves as an incubator, helping early-stage ventures and startups in the cannabis sector through funding, mentoring, and training. It is also engaged in legal cannabis retail and owns and manages retail cannabis ventures.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
Comparables
Valuation
|
Metric
|
PNXP
|
GLAS.A.U
|
TRUL
|
|---|---|---|---|
Price/Earnings (Normalized) | 73.13 | — | 29.10 |
Price/Book Value | 1,356.20 | 10.60 | 1.27 |
Price/Sales | — | 3.19 | 1.56 |
Price/Cash Flow | 3,647.80 | 60.71 | 29.02 |
Price/Earnings
PNXP
GLAS.A.U
TRUL
Financial Strength
|
Metric
|
PNXP
|
GLAS.A.U
|
TRUL
|
|---|---|---|---|
Quick Ratio | 0.00 | 0.28 | 2.82 |
Current Ratio | 0.00 | 0.43 | 4.99 |
Interest Coverage | — | −5.96 | −2.51 |
Quick Ratio
PNXP
GLAS.A.U
TRUL
Profitability
|
Metric
|
PNXP
|
GLAS.A.U
|
TRUL
|
|---|---|---|---|
Return on Assets (Normalized) | 2.68% | −10.48% | −3.82% |
Return on Equity (Normalized) | 8.58% | −33.34% | −7.27% |
Return on Invested Capital (Normalized) | 2.71% | −11.75% | −2.43% |
Return on Assets
PNXP
GLAS.A.U
TRUL
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Xhbpgmydn | Dnfl | $79.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Hfbsvbhd | Jgxnqsw | $72.0 Bil | |||
| Haleon PLC ADR
HLN
| Pbysgpqgs | Mqxhd | $37.3 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Ryjhbjdk | Yynk | $12.8 Bil | |||
| Viatris Inc
VTRS
| Xrphvhph | Kfdg | $12.7 Bil | |||
| Catalent Inc
CTLT
| Yzhrwkj | Qpygt | $10.2 Bil | |||
| Perrigo Co PLC
PRGO
| Pqccgvxlb | Fqv | $3.5 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Llmdhxvgb | Hsbfzpd | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Tylmpdkb | Dqd | $2.9 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Jfzhpsyz | Mpvk | $2.8 Bil |